Doctors at PGIMER develop novel imaging modality for Cushing's disease diagnosis

This technique has been developed for the first time in the world and PGIMER has already applied for its patent.

Published On 2021-03-19 04:00 GMT   |   Update On 2021-03-19 04:00 GMT

Chandigarh: Post Graduate Institute of Medical Education & Research (PGIMER) accomplished another milestone as the Endocrinology Department in collaboration with the Department of Nuclear Medicine developed a novel imaging modality for the diagnosis of Cushing's disease. This technique has been developed for the first time in the world and PGIMER has already applied for its patent....

Login or Register to read the full article

Chandigarh: Post Graduate Institute of Medical Education & Research (PGIMER) accomplished another milestone as the Endocrinology Department in collaboration with the Department of Nuclear Medicine developed a novel imaging modality for the diagnosis of Cushing's disease.

This technique has been developed for the first time in the world and PGIMER has already applied for its patent.

Cushing's syndrome is a hormonal disorder that results in weight gain with thinning of extremities, hypertension, loss of bone mass, changes in mood like depression, hair loss, striae on the abdomen, bluish patches on the skin.

Also Read: Very high degree of negligence is needed for doctors conviction: Bombay HC absolves 3 doctors of IPC 304 A

Once diagnosed, the treatment is rewarding in terms of remission of diabetes & hypertension, decrease in weight and improvement in bones strength and mood.

Also Read: Nagpur doctor gets 6-month jail after pet dog bites 9-year-old boy

Tags:    
Article Source : ANI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News